Upgrade to see committee overlap, performance context, and full expert analysis.
TW congressional trades
8 matched disclosures
TW congressional trades snapshot
This page summarizes public STOCK Act disclosures involving TW. It is useful for seeing which lawmakers reported TW transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.
Jan 13, 2026
Public House and Senate STOCK Act disclosures normalized by Congressional Trader.
Filing date can trail transaction date. This page is for research and monitoring, not investment advice.
What the TW congressional trade page shows
Congressional Trader tracks 8 public STOCK Act disclosures for TWacross 2 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.
The most recent TW filing shown here was filed on Jan 13, 2026 by Julia Letlow as a sale. Related lawmakers include Byron Donalds, Julia Letlow.
Top lawmakers for TW
Pro performance summary
Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.
Compare Pro plansUpgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
FAQ
Which lawmakers traded TW?
Recent TW disclosures include Byron Donalds, Julia Letlow.
What is the buy/sell mix for TW?
The visible sample currently shows 5 purchases and 3 sales or partial sales.
Should I trade based on TW disclosures?
No. This page summarizes public filings for research and monitoring. It is not investment advice.